We learn with curiosity the research by Sutherland et al1 exploring the affiliation of CD19-targeted chimeric antigen receptor (CAR) T-cell remedy with hypogammaglobulinemia, an infection, and mortality. This analysis presents an important contribution to understanding immunoglobulin deficiencies following CAR T-cell remedy, offering actionable insights for clinicians managing posttreatment problems in hematologic malignancies.1 Nonetheless, a number of solutions warrant additional dialogue to higher contextualize these findings.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
$9.99
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28